BMEA

Biomea Fusion, Inc. Common Stock

1.30

USD

BMEA Earnings Reports

Positive Surprise Ratio

BMEA beat 7 of 19 last estimates.

37%

Next Report

Next Week

Date of Next Report

Apr 06, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.25

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-69.14%

Biomea Fusion, Inc. Common Stock earnings per share and revenue

On --, BMEA reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.25 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

Acumen Pharmaceuticals, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.46

Actual

-$0.41

Surprise

+11.29%

Spero Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.20

Actual

$0.53

Surprise

+359.80%

Humacyte, Inc. Common Stock

Report Date

Mar 27, 2026 For Q4 25

Estimate

-$0.13

Actual

-$0.13

Surprise

+3.20%

Alpha Cognition Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.30

Surprise

-8.93%

Rani Therapeutics Holdings, Inc. Class A Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.07

Surprise

-2.94%

Cognition Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.02

Surprise

+76.47%

Entera Bio Ltd. Ordinary Shares

Report Date

Mar 27, 2026 For Q4 25

Estimate

-$0.09

Actual

-$0.07

Surprise

+23.75%

Quantum Biopharma Ltd. Class B Subordinate Voting Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

Actual

-$0.71

Surprise

CollPlant Biotechnologies Ltd Ordinary Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.67

Surprise

-245.72%

FAQ

What were Biomea Fusion, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Biomea Fusion, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to Biomea Fusion, Inc. Common Stock's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Biomea Fusion, Inc. Common Stock expected to report next?

The next earning report is scheduled for Apr 06, 2026.

What are the forecasts for Biomea Fusion, Inc. Common Stock's next earnings report?

Based on 9 analysts, Biomea Fusion, Inc. Common Stock is expected to report EPS of -$0.25 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.